CNR1 and obesity disorder: Focusingon antagonism, in a mouse model of Parkinson’s disease, antagonismof CB1 with AM251 improved factors such as balance andmuscle strength but increased anxious- and depressive-like behaviors.Antagonism was also considered as a treatment for obesity.